The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:47
|
作者
Hu, Meiyi [1 ,2 ,3 ]
Zhang, Li [2 ,3 ]
Ruan, Zheng [1 ,2 ,3 ]
Han, Peiheng [2 ,3 ]
Yu, Yujuan [2 ,3 ]
机构
[1] Beijing Technol & Business Univ BTBU, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China
[2] Nanchang Univ, Inst Nutr, State Key Lab Food Sci & Technol, Nanchang 330047, Jiangxi, Peoples R China
[3] Nanchang Univ, Sch Food Sci, Nanchang 330047, Jiangxi, Peoples R China
关键词
citrus peel; liver metabolites; gut flora; non-alcoholic fatty liver disease; pomelo; orange; FECAL MICROBIOTA; OBESITY; PECTINS;
D O I
10.3390/foods10123022
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Gannan navel orange and Jinggang pomelo, belonging to the genus Citrus, are good sources of phenolic compounds, which are mainly concentrated in the peel. These phenolic compounds are considered promising in the prevention and treatment of non-alcoholic fatty liver disease (NAFLD). In order to maximize nutrients retention and bioactivity in the peel, pomelo peel and orange peel were processed using freeze-drying technology and mixed in the ratio (pomelo peel powder 50% and orange peel powder 50%) to make citrus peel powder (CPP). The purpose of this study was to explore new strategies and mechanisms associated with the consumption of CPP to alleviate nonalcoholic fatty liver injury, lipid metabolism disorders, and gut microbiota dysbiosis in obese mice induced by high-fat diet (HFD). The results showed that after 12 weeks of CPP administration, CPP supplementation had a strong inhibitory effect on HFD-induced weight gain, hepatic fat accumulation, dyslipidemia, and the release of pro-inflammatory cytokines. In particular, CPP modulates the composition of the intestinal flora, such as increasing the relative abundance of phylum Firmicutes, genus Faecalibaculum, genus Lactobacillus, genus Dubosiella, and genus Lachnospiraceae_NK4A136_ group and decreasing the relative abundance of phylum Bacteroidota, genus Helicobacter, and genus Bacteroides. These results suggest that CPP has a preventive effect on NAFLD, which can be related to the regulation of intestinal flora.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
    Koralegedara, Iresha Sandamali
    Warnasekara, Janith Niwanthaka
    Rathnayake, Ashani
    Dayaratne, Korale Gedara
    Agampodi, Suneth Buddhika
    BMJ OPEN GASTROENTEROLOGY, 2022, 9 (01):
  • [22] Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
    Jadhav, Pranali A.
    Thomas, Asha B.
    Nanda, Rabindra K.
    Chitlange, Sohan S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (12) : 1324 - 1333
  • [23] Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
    Koukias, Nikolaos
    Buzzetti, Elena
    Tsochatzis, Emmanuel A.
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 184 - 194
  • [24] The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
    Houttu, Veera
    Boulund, Ulrika
    Grefhorst, Aldo
    Soeters, Maarten R.
    Pinto-Sietsma, Sara-Joan
    Nieuwdorp, Max
    Holleboom, Adriaan G.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [25] Gut microbiota and non-alcoholic fatty liver disease: new insights
    Aron-Wisnewsky, J.
    Gaborit, B.
    Dutour, A.
    Clement, K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 338 - 348
  • [26] Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
    Katherine J. P. Schwenger
    Colin M. Bolzon
    Carrie Li
    Johane P. Allard
    European Journal of Nutrition, 2019, 58 : 1771 - 1784
  • [27] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
  • [28] The effects of the voglibose on non-alcoholic fatty liver disease in mice model
    Bae, Jaehyun
    Lee, Ji Young
    Shin, Eugene
    Lee, Minyoung
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
    Chen, Dongliang
    Wang, Yuanfei
    Yang, Jianmei
    Ou, Wanyi
    Lin, Guiru
    Zeng, Ze
    Lu, Xiaomin
    Chen, Zumin
    Zou, Lili
    Tian, Yaling
    Wu, Aiping
    Keating, Shelley E.
    Yang, Qinhe
    Lin, Chenli
    Liang, Yinji
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
    Schwenger, Katherine J. P.
    Bolzon, Colin M.
    Li, Carrie
    Allard, Johane P.
    EUROPEAN JOURNAL OF NUTRITION, 2019, 58 (05) : 1771 - 1784